A股直线涨停!迈威与谷歌系达成5.71亿美元重磅交易

MedTrend医趋势
27 Jun

6月26日,谷歌控股的Alphabet集团旗下生命科学子公司Calico,敲定了一项高达5.71亿美元的生物医药交易,目的是获取迈威生物(Mabwell Bioscience)研究中的IL-11靶向疗法相关权利。这项交易包括一款针对与年龄相关疾病的临床阶段单克隆抗体(mAb)。6月27日(今日),迈威生物在A股直接涨停。除了与Calico的交易,同日,迈威生物还授权其新一代长效G-CSF(升白药)...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10